Mumbai
Tier 1
$6,000 - $28,000
Higher estimates usually include reconstruction, targeted medicines, or complex multi-modality care.
Breast oncology cost
Plan breast cancer care with USD ranges for surgery, chemotherapy, radiation, HER2-targeted therapy, reconstruction, hormone therapy, and follow-up across Indian cities.
How much does breast cancer treatment cost in India?
Breast cancer treatment in India commonly ranges from $4,000 to $28,000 or more depending on stage, surgery type, reconstruction, chemotherapy cycles, radiation, hormone therapy, HER2-targeted medicines, and hospital city. Early-stage surgery-only treatment can be much lower than HER2-positive or advanced disease that needs multiple medicines and longer follow-up.
City-wise cost
These ranges are planning bands. A hospital-backed quote should be requested after reports, diagnosis, and fitness details are reviewed.
Tier 1
$6,000 - $28,000
Higher estimates usually include reconstruction, targeted medicines, or complex multi-modality care.
Tier 1
$5,800 - $27,000
Useful for tumor board review and reconstruction or advanced drug planning.
Tier 1
$6,000 - $28,000
Often selected for premium breast units and international coordination.
Tier 1
$5,500 - $25,500
Strong for surgical oncology, medical oncology, radiation, and genetics review.
Tier 1
$5,200 - $24,500
Established option for breast surgery, chemotherapy, and radiation.
Tier 1
$5,100 - $24,000
Can offer comprehensive breast cancer care with efficient planning.
Major metro
$4,700 - $22,000
Good planned-care option when reconstruction and advanced drugs are clarified.
Major metro
$4,600 - $21,500
Often competitive for surgery, chemo, and radiation sequencing.
Major metro
$4,400 - $20,500
Useful for eastern-region patients needing breast oncology access.
Tier 2
$4,000 - $18,500
Can fit selected early or stable cases with strong pathology and oncology support.
Tier 2
$4,000 - $18,000
Lower non-medical cost can help during repeated chemo or radiation visits.
Tier 2
$4,200 - $19,000
Suitable when surgical, medical, and radiation oncology coordination is confirmed.
Tier choice
Advanced disease, reconstruction, genetics, rare subtypes, or high-cost targeted therapy may need Tier 1 depth.
Selected surgery, chemotherapy, radiation, and follow-up can work well in Tier 2 cities with strong oncology systems.
A lower quote is risky if receptor status, stage, and drug protocol are not confirmed.
Included
Breast surgery, chemotherapy cycle, radiation course, or targeted therapy as quoted.
Each phase should be listed separately.
Room or day-care services, nursing, and routine monitoring for the planned phase.
Most chemo is day-care based.
Basic anesthesia, pain medicines, anti-nausea medicines, and standard in-hospital support.
High-cost injections can be separate.
Surgical oncologist, medical oncologist, radiation oncologist, or plastic surgeon as required.
Reconstruction adds team cost.
Not included
HER2 medicines, CDK4/6 inhibitors, immunotherapy, or imported drugs if not in the quote.
Drug protocol drives long-term cost.
Implant, flap reconstruction, symmetrization, or staged cosmetic correction.
Always separate from basic cancer surgery.
BRCA or broader hereditary cancer testing when recommended.
Useful in selected young or family-history cases.
Chemo cycles, radiation sessions, follow-up scans, hotel stay, and attendant support.
Plan total journey cost.
Cost drivers
Early-stage surgery may be simpler than locally advanced or metastatic disease.
Staging scans matter.
ER, PR, HER2, and Ki-67 results influence medicines and duration.
HER2-positive care can be costly.
Lumpectomy, mastectomy, sentinel node biopsy, axillary clearance, or reconstruction change cost.
Ask what is planned.
Conventional, hypofractionated, boost, or advanced planning affects price and stay.
Session count matters.
Chemotherapy, hormone therapy, targeted medicines, and maintenance drugs vary widely.
Get drug names and cycle count.
Reports
The report checklist is different for each treatment so every cost page avoids generic duplicated content.
Breast cancer estimates need pathology and receptor details before cost comparison is meaningful.
Confirms invasive type, grade, and whether slide review is needed.
These markers influence chemotherapy, hormone therapy, targeted therapy, and prognosis discussions.
Mammogram, ultrasound, breast MRI, or PET CT helps define local and distant spread.
Any previous surgery, chemo, radiation, or hormone therapy must be shared.
Hospital selection
Surgical, medical, radiation oncology, pathology, radiology, and reconstruction support should align.
Important for sequencing.
Confirm ER, PR, HER2, Ki-67, slide review, and repeat testing policy.
Treatment depends on markers.
Ask about machine availability, planning time, session count, and boost requirement.
Affects stay length.
Confirm chemotherapy and targeted medicine names, brands, doses, and cycle count.
Prevents cost surprises.
Patient journey
Biopsy and receptor reports confirm the breast cancer subtype.
The team decides whether surgery, chemotherapy, or another therapy should come first.
The patient compares surgery, radiation, chemo cycles, drug protocol, and stay cost.
Long-term hormone therapy, scans, wound care, and local oncology follow-up are planned.
Recovery planning
Drain care, arm exercises, wound review, pathology report timing, and stitch removal should be planned.
Blood-count monitoring, side-effect instructions, nutrition, and fever response need clarity.
Hormone therapy, surveillance scans, lymphedema precautions, and local follow-up should be documented.
Questions
Early-stage disease may need surgery and limited therapy, while advanced or HER2-positive disease can require chemotherapy, radiation, targeted medicines, and repeated visits.
Not always. Reconstruction, implants, flaps, or cosmetic correction should be listed separately in the quote.
Selected stable cases can be treated in Tier 2 cities if pathology, surgical oncology, medical oncology, radiation, and emergency support are reliable.
Biopsy, histopathology, ER/PR/HER2, Ki-67, mammogram or MRI, staging scans, and prior treatment records are important.
HER2-positive treatment may require targeted medicines for multiple cycles, and these drugs can be a major cost component.
Surgery-only plans may be shorter, while chemotherapy and radiation plans can require multiple weeks or repeated visits.
Sometimes yes, if the protocol, drug availability, and local oncologist handoff are clear.
Yes. Virello can compare stage, markers, treatment sequence, inclusions, drug protocol, city fit, and hospital capability.